コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f expression of endothelial cell luminal and junctional adhesion molecules.
4 or mouse homologs of the reovirus receptor, junctional adhesion molecule 1 (JAM1), but not the coxsa
7 of one such transcript, F11R (also known as junctional adhesion molecule 1, JAM1), in hypoxia is dep
9 areas, whereas an increase in expression of junctional adhesion molecule-1 (JAM-1) in blood vessels
13 the main proteins associated with it such as junctional adhesion molecule-1 and vascular endothelial
19 V attachment and entry is mediated by feline junctional adhesion molecule A (fJAM-A), which binds to
20 attachment to cell surface carbohydrate and junctional adhesion molecule A (JAM-A) and internalizati
21 receptors have been identified for reovirus, junctional adhesion molecule A (JAM-A) and Nogo-66 recep
22 (T1L/53) and type 3 Dearing/55 (T3D/55) use junctional adhesion molecule A (JAM-A) as a receptor.
23 Mammalian orthoreoviruses use glycans and junctional adhesion molecule A (JAM-A) as attachment rec
27 trocyte TJs of claudin 1 (CLDN1), CLDN4, and junctional adhesion molecule A (JAM-A) subunits is induc
28 he cytoplasmic tail of the ZO-1 PDZ3 ligand, junctional adhesion molecule A (JAM-A) to determine how
35 ll adhesion molecule (PECAM; CD31), CD99 and junctional adhesion molecule A (JAM-A), but apparently n
41 t in intestinal epithelial barrier function, junctional adhesion molecule A knockout mice, F11r(-/-)
43 s contain the tight junction proteins JAM-A (junctional adhesion molecule A), occludin, and cingulin.
46 pression of tight junction proteins, such as junctional adhesion molecule-A (JAM)-A, occludin, and zo
47 mab, two humanized IgG4s which bind to human Junctional Adhesion Molecule-A (JAM-A) and alpha4 integr
48 n reovirus binds to cell surface glycans and junctional adhesion molecule-A (JAM-A) and enters cells
49 protein sigma1 engages glycan receptors and junctional adhesion molecule-A (JAM-A) and is thought to
50 vel of integral membrane proteins: occludin, junctional adhesion molecule-A (JAM-A) and N-cadherin at
52 lymphatic endothelial cells, wherein a ROCK2/junctional adhesion molecule-A (JAM-A) complex emerges t
53 ted expression of the tight junction protein junctional adhesion molecule-A (JAM-A) in the HepG2 huma
66 ction, sigma1 engages sialylated glycans and junctional adhesion molecule-A (JAM-A), triggering uptak
70 1b(-/-), and CD18(null) mice with wild-type, junctional adhesion molecule-A(-/-), ICAM-1(null), ICAM-
71 ing occludin, claudin-5, zonula occludens-1, junctional adhesion molecule-A, and endothelial cell-sel
72 cumulation of vascular endothelial-cadherin, junctional adhesion molecule-A, and platelet/endothelial
73 ent of key TJ proteins: occludin, claudin-1, junctional adhesion molecule-A, and zonula occludens-1.
75 using new transgenic fish lines that express Junctional Adhesion Molecules and functional interferenc
78 y means of a transgenic marking method, that junctional adhesion molecule B (JAM-B) marks a previousl
79 e-derived miR-330-3p increased expression of junctional adhesion molecule B in a noncanonical fashion
80 g integrin alpha3beta1, VE-cadherin, ICAM-2, junctional adhesion molecule-B (JAM-B), laminin, and cel
81 injury, characterized by lower expression of junctional adhesion molecule C (JAM-C) at EC junctions,
82 dy was undertaken to investigate the role of junctional adhesion molecule C (JAM-C) in mediating leuk
87 ns and/or transmembrane adhesions, including junctional adhesion molecule-C (JAM-C) and myelin-associ
92 e protein of the immunoglobulin superfamily, junctional adhesion molecule-C (JAM-C), is critically re
95 ing defective 3 (Pard3) polarity protein and Junctional adhesion molecule-C (JamC) adhesion molecule
96 g protein ZO-1 and the transmembrane protein junctional adhesion molecule, causing an ectopic assembl
97 ering the expression and distribution of two junctional adhesion molecules, CD31 and vascular endothe
100 s for endothelial-specific homologs to human junctional adhesion molecule (JAM) and A33-Ag, we identi
101 superfamily that shows 44% similarity to the junctional adhesion molecule (JAM) and maps to chromosom
105 l cell adhesion molecule-1 (PECAM-1) (CD31), junctional adhesion molecule (JAM), and VE-cadherin away
111 m cell-cell contacts-claudins, occludin, and junctional adhesion molecule (JAM)-plus peripheral prote
112 lized within the tight junction (TJ) include Junctional Adhesion Molecule (JAM-A), which has been imp
113 Initial investigations into TJ proteins and junctional adhesion molecules (JAM) in cancer suggested
115 ross the ventral face of the somite and that junctional adhesion molecules (JAMs) mediate this requir
117 and Adenovirus Receptor (CAR) that binds to Junctional Adhesion Molecule-like (JAM-L) expressed on l
118 Recent discovery of the interaction between junctional adhesion molecule-like protein (JAML) and CAR
119 yd TIL is supported by interactions between junctional adhesion molecule-like protein (JAML) on T ce
120 rovide the first evidence that PMN-expressed junctional adhesion molecule-like protein (JAML) regulat
122 r subpleural ILAs in MESA, and two of these, junctional adhesion molecule-like protein and GTP cycloh
123 ansmembrane proteins occludin, claudins, and junctional adhesion molecules to many cytoplasmic protei
124 s to a recently identified molecule known as Junctional Adhesion Molecule, which is concentrated at t